Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BBBY
BBBY logo

BBBY Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bed Bath & Beyond Inc (BBBY) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
5.810
1 Day change
1.22%
52 Week Range
12.650
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Bed Bath & Beyond Inc (BBBY) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available. The company's financial performance is weak, with declining revenue, net income, and EPS. While there are some positive technical indicators and a chance of short-term price increases, the lack of significant positive catalysts, weak financials, and neutral sentiment from hedge funds and insiders suggest that holding off on investing in this stock is the better choice.

Technical Analysis

The MACD histogram is positive and expanding, suggesting bullish momentum. The RSI is in the neutral zone at 69.318, and moving averages are converging, indicating no clear trend. Key resistance levels are at 5.255 and 5.525, while support levels are at 4.38 and 4.11. The stock has a 70% chance of increasing by 10.95% in the next day and 47.53% in the next month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
8

Positive Catalysts

  • The MACD is expanding positively, and there is a 70% chance of short-term price increases. Gross margin increased by 7.05% YoY in the latest quarter.

Neutral/Negative Catalysts

  • Revenue, net income, and EPS have significantly declined YoY. Analysts have lowered price targets, and there is no recent news or significant insider/hedge fund activity. The market sentiment is neutral, and there are no recent congress trading data or influential figure transactions.

Financial Performance

In Q4 2025, revenue dropped by 9.80% YoY to $273.43M, net income dropped by 74.31% YoY to -$20.88M, and EPS dropped by 81.93% YoY to -0.3. However, gross margin increased by 7.05% YoY to 24.6%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets recently. Piper Sandler reduced the target to $8 from $10, maintaining a Neutral rating, citing uncertainty in the company's framework. Wedbush lowered the target to $7 from $13 but maintained an Outperform rating, noting some positive trends in website data and incremental optimism for the core business.

Wall Street analysts forecast BBBY stock price to rise
5 Analyst Rating
Wall Street analysts forecast BBBY stock price to rise
1 Buy
4 Hold
0 Sell
Hold
Current: 5.740
sliders
Low
8
Averages
11.67
High
17
Current: 5.740
sliders
Low
8
Averages
11.67
High
17
Piper Sandler
Neutral
downgrade
$10 -> $8
AI Analysis
2026-02-24
Reason
Piper Sandler
Price Target
$10 -> $8
AI Analysis
2026-02-24
downgrade
Neutral
Reason
Piper Sandler lowered the firm's price target on Bed Bath & Beyond to $8 from $10 and kept a Neutral rating on the shares following a Q4 print that showed sequential improvement in the core business. While revenue was still down year-over-year, internal initiatives such as SKU consolidation appear to be gaining traction, Piper notes. The firm remains on the sidelines given the amount of uncertainty in bringing its three-pillar framework together.
Wedbush
Outperform
to
NULL
downgrade
$13 -> $7
2026-02-18
Reason
Wedbush
Price Target
$13 -> $7
2026-02-18
downgrade
Outperform
to
NULL
Reason
Wedbush lowered the firm's price target on Bed Bath & Beyond to $7 from $13 to reflect a more modest EV-to-EBITDA multiple of 8 times on 2027 EBITDA estimate, while keeping an Outperform rating on the shares. Looking at Q4 results, the firm sees more upside than downside risk to topline estimates with website data trending positively during the quarter - these positive trends have persisted thus far into Q1, giving Wedbush incremental optimism that the core business is finally inflecting positive.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BBBY
Unlock Now

People Also Watch